These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39087349)

  • 1. Thrombin Generation Is Associated With Extracellular Vesicle and Leukocyte Lipid Membranes in Atherosclerotic Cardiovascular Disease.
    Protty MB; Tyrrell VJ; Allen-Redpath K; Soyama S; Hajeyah AA; Costa D; Choudhury A; Mitra R; Sharman A; Yaqoob P; Jenkins PV; Yousef Z; Collins PW; O'Donnell VB
    Arterioscler Thromb Vasc Biol; 2024 Sep; 44(9):2038-2052. PubMed ID: 39087349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylthreonine is a procoagulant lipid detected in human blood and elevated in coronary artery disease.
    Hajeyah AA; Protty MB; Paul D; Costa D; Omidvar N; Morgan B; Iwasaki Y; McGill B; Jenkins PV; Yousef Z; Allen-Redpath K; Soyama S; Choudhury A; Mitra R; Yaqoob P; Morrissey JH; Collins PW; O'Donnell VB
    J Lipid Res; 2024 Jan; 65(1):100484. PubMed ID: 38103786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular histones: a unifying mechanism driving platelet-dependent extracellular vesicle release and thrombus formation in COVID-19.
    Eustes AS; Ahmed A; Swamy J; Patil G; Jensen M; Wilson KM; Kudchadkar S; Wahab A; Perepu U; Miller FJ; Lentz SR; Dayal S
    J Thromb Haemost; 2024 Sep; 22(9):2514-2530. PubMed ID: 38815756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different Potential of Extracellular Vesicles to Support Thrombin Generation: Contributions of Phosphatidylserine, Tissue Factor, and Cellular Origin.
    Tripisciano C; Weiss R; Eichhorn T; Spittler A; Heuser T; Fischer MB; Weber V
    Sci Rep; 2017 Jul; 7(1):6522. PubMed ID: 28747771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary n-3 polyunsaturated fatty acids alter the number, fatty acid profile and coagulatory activity of circulating and platelet-derived extracellular vesicles: a randomized, controlled crossover trial.
    Bozbas E; Zhou R; Soyama S; Allen-Redpath K; Mitchell JL; Fisk HL; Calder PC; Jones C; Gibbins JM; Fischer R; Hester S; Yaqoob P
    Am J Clin Nutr; 2024 May; 119(5):1175-1186. PubMed ID: 38484976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates.
    Brambilla M; Camera M; Colnago D; Marenzi G; De Metrio M; Giesen PL; Balduini A; Veglia F; Gertow K; Biglioli P; Tremoli E
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):947-53. PubMed ID: 18292391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicle-associated procoagulant activity is highest the first 3 hours after trauma and thereafter declines substantially: A prospective observational pilot study.
    Rognes IN; Hellum M; Ottestad W; Bache KG; Eken T; Henriksson CE
    J Trauma Acute Care Surg; 2021 Oct; 91(4):681-691. PubMed ID: 34225342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylserine expression on the platelet membrane of patients with myeloproliferative disorders and its effect on platelet-dependent thrombin formation.
    Presseizen K; Friedman Z; Shapiro H; Radnay J; Ellis MH
    Clin Appl Thromb Hemost; 2002 Jan; 8(1):33-9. PubMed ID: 11991237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.
    Gheldof D; Haguet H; Dogné JM; Bouvy C; Graux C; George F; Sonet A; Chatelain C; Chatelain B; Mullier F
    J Thromb Thrombolysis; 2017 Feb; 43(2):224-232. PubMed ID: 28074413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction.
    Gasecka A; Nieuwland R; Budnik M; Dignat-George F; Eyileten C; Harrison P; Huczek Z; Kapłon-Cieślicka A; Lacroix R; Opolski G; Pluta K; van der Pol E; Postuła M; Leroyer A; Siljander P; Sturk A; Filipiak KJ
    Platelets; 2020; 31(1):26-32. PubMed ID: 30585111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of platelet aminophospholipid externalization reveals fatty acids as molecular determinants that regulate coagulation.
    Clark SR; Thomas CP; Hammond VJ; Aldrovandi M; Wilkinson GW; Hart KW; Murphy RC; Collins PW; O'Donnell VB
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):5875-80. PubMed ID: 23530199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity.
    Guerreiro EM; Kruglik SG; Swamy S; Latysheva N; Østerud B; Guigner JM; Sureau F; Bonneau S; Kuzmin AN; Prasad PN; Hansen JB; Hellesø OG; Snir O
    J Thromb Haemost; 2024 May; 22(5):1463-1474. PubMed ID: 38266680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary Nitrate Supplementation Reduces Circulating Platelet-Derived Extracellular Vesicles in Coronary Artery Disease Patients on Clopidogrel Therapy: A Randomised, Double-Blind, Placebo-Controlled Study.
    Burnley-Hall N; Abdul F; Androshchuk V; Morris K; Ossei-Gerning N; Anderson R; Rees DA; James PE
    Thromb Haemost; 2018 Jan; 118(1):112-122. PubMed ID: 29304531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
    Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
    J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response.
    Pasalic L; Wing-Lun E; Lau JK; Campbell H; Pennings GJ; Lau E; Connor D; Liang HP; Muller D; Kritharides L; Hogg PJ; Chen VM
    J Thromb Haemost; 2018 Jun; 16(6):1198-1210. PubMed ID: 29569428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Procoagulant Activity on Blood Cells after Acute Ischemic Stroke.
    Yao Z; Wang L; Wu X; Zhao L; Chi C; Guo L; Tong D; Yang X; Dong Z; Deng R; Novakovic VA; Thatte HS; Bi Y; Tian Y; Shi J; Zhou J; Kou J; Hu S
    Transl Stroke Res; 2017 Feb; 8(1):83-91. PubMed ID: 27650774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased circulating platelet-derived extracellular vesicles in severe COVID-19 disease.
    Helin T; Palviainen M; Lemponen M; Maaninka K; Siljander P; Joutsi-Korhonen L
    Platelets; 2024 Dec; 35(1):2313362. PubMed ID: 38380806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-released extracellular vesicles: the effects of thrombin activation.
    Suades R; Padró T; Vilahur G; Badimon L
    Cell Mol Life Sci; 2022 Mar; 79(3):190. PubMed ID: 35288766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with acute and chronic coronary syndromes have elevated long-term thrombin generation.
    Yip C; Seneviratna A; Tan SH; Khaing T; Chan SP; Loh J; Lee CH; Low AF; Drum CL; Poh SC; Gibson CM; Ohman EM; Richards AM; Chan MY
    J Thromb Thrombolysis; 2020 Aug; 50(2):421-429. PubMed ID: 32077007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation potential and the integrated omics of extracellular vesicles from COVID-19 positive patient plasma.
    Setua S; Thangaraju K; Dzieciatkowska M; Wilkerson RB; Nemkov T; Lamb DR; Tagaya Y; Boyer T; Rowden T; Doctor A; D'Alessandro A; Buehler PW
    Sci Rep; 2022 Dec; 12(1):22191. PubMed ID: 36564503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.